Research programme: pain therapeutic - BioMed Valley DiscoveriesAlternative Names: BVD-MOR
Latest Information Update: 26 Feb 2016
At a glance
- Originator BioMed Valley Discoveries
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 25 Feb 2016 Discontinued - Preclinical for Pain in USA (unspecified route)
- 15 Feb 2013 Preclinical trials in Pain in USA (unspecified route)